titlesubmit dateissue date
Now showing items 1-6 of 6
A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia
Droplet Microfluidics for the ex Vivo Expansion of Human Primary Multiple Myeloma Cells.
GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy
MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia
Novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia
Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms